Publication; Publicity. Consultant may not publish or refer to Work Product, in whole or in part, without the prior express written consent of the Company. Consultant will not use the name, logo, trade name, service mark, or trademark, or any simulation, abbreviation, or adaptation of same, or the name of the Company or any of its affiliates for publicity, promotion, or other uses without the Company’s prior written consent.
Publication; Publicity. Work Product may not be published or referred to, in whole or in part, by Consultant without the prior express written consent of Voyager. Consultant shall not use the name, logo, trade name, service xxxx, or trademark, or any simulation, abbreviation, or adaptation of same, or the name of Voyager or its subsidiaries for publicity, promotion, or similar non-regulatory uses without Voyager’s prior written consent.
Publication; Publicity. University shall have the right to publish or otherwise present the results of the Research Program at symposia or academic meetings; provided that it first submit all proposed publications and presentations to the Sponsor [ * ] prior to submission of such proposed publication or presentation to a journal, editor or other third party. Sponsor shall have [ * ] after the receipt of the publication or presentation to review and comment upon it. Upon notice by Sponsor that Sponsor reasonably believes a patent application relating to an Invention should be filed prior to the publication or presentation or that exigent circumstances exist necessitating a delay in publication or presentation. Sponsor may request the University to delay and the University agrees to delay submission of the publication or presentation for up to an additional [ * ] from the date of Sponsor’s notification to the University or until a patent application or applications are filed, whichever come first. University shall give Sponsor appropriate recognition and credit for its contributions in all such publications and presentations at symposia or meetings including, without limitation, right of authorship and acknowledgement of QBI’s sponsorship. Any publicity, including press releases, press conferences or other disclosures, about the Research Program (including, without limitation, the establishment of any aspects of the Program, its progress or any results generated therefrom) shall be permitted only with the prior written approval of both the Sponsor and the University.
Publication; Publicity. Without limiting Section 7 (Confidentiality & Non-Use), Consultant shall not publish any Work Product, in whole or in part, without the prior express written consent of Jounce. Consultant shall not use the name, logo, trade name, service mark, or trademark, or any simulation, abbreviation, or adaptation of same, or the name of Jounce or its subsidiaries for publicity, promotion, or similar non-regulatory uses without Jounce’s prior written consent.
Publication; Publicity. Consultant may not publish or refer to Work Product, in whole or in part, without the prior express written consent of Civitas. Consultant will not use the name, logo, trade name, service xxxx, or trademark, or any simulation, abbreviation, or adaptation of same, or the name of Civitas or any of its affiliates for publicity, promotion, or other uses without Civitas’ prior written consent. Notwithstanding the foregoing, Consultant may, without obtaining Civitas’ prior consent, generally disclose a description of the services he provided to Civitas on his resume or in other instances where he is generally describing his professional accomplishments.
Publication; Publicity. 1) Each party agrees that it may be in their best interests to present Scientific Information or Data at conferences or to publish in journals such Scientific Information or Data, subject to the other party’s prior written consent for publication, which shall not be unreasonably withheld, delayed or conditioned. If a party wishes to present or publish any Scientific Information or Data that has not been previously disclosed to the public, such party shall submit a manuscript of the conference abstract or the research paper for the other party’s review prior to submission to the conference or the publisher. The non-publishing party shall have thirty (30) days after the receipt from the publishing party of such manuscript to review the manuscript and to request reasonable modifications thereof. If the non-publishing party does not provide any request for any modifications during such review period or, if the non-publishing party provides a request for modification, then after such request is complied with by the publishing party to the reasonable satisfaction of the non-publishing party, the publishing party may submit the manuscript for publication. Unless approved by the non-publishing party in writing, such publication shall not contain any confidential information of the non-publishing party. If such publication contains patentable technology, the non-publishing party may request the publishing party to delay the publication for a period reasonably necessary for the non-publishing party to obtain patent protection therefor.
2) SALMEDIX may issue a press release or public announcement concerning any aspect of the development or commercialization of the Compound and/or the Product, a courtesy copy of which shall be provided to F-DE no less than five (5) business days prior to any such release. No other press release or public announcement shall be made by either party concerning the execution of this Agreement or the terms and conditions hereof, without the prior written consent of the non-disclosing party, which consent shall not be unreasonably withheld, conditioned or delayed. Notwithstanding the foregoing, SALMEDIX may disclose the existence of this Agreement and the terms and conditions hereof, without the prior written consent of F-DE, as reasonably necessary in connection with the due diligence process associated with any future capital investment in SALMEDIX or the negotiation or exploration of a possible strategic transaction.
Publication; Publicity. Consultant may not publish or refer to Work Product, in whole or in part, without the prior express written consent of BeiGene. Consultant will not use the name, logo, trade name, service xxxx, or trademark, or any simulation, abbreviation, or adaptation of same, or the name of BeiGene or any of its affiliates for publicity, promotion, or other uses without BeiGene’s prior written consent.
Publication; Publicity. In accordance with this subparagraph (a), HCRI shall have the right to publish or otherwise publicly disclose the results of the Study and other information gained in the course of this Agreement after the occurrence of the first of the following: (i) Sponsor’s initial publication; (ii) written notification from Sponsor that an initial publication is no longer planned; (iii) one (1) year after termination of the Study or data lock. Prior to any publication, for a period of five (5) year following the date on which HCRI’s right to publish arises, in the interest of protecting patent rights and Sponsor Confidential Information, HCRI shall submit manuscripts, abstracts and similar material generated by HCRI as a result of this Agreement (“Publications”) to an independent publications committee, for review and comment at least forty-five (45) days prior to the planned publication or disclosure date. The independent publications committee will include representation by HCRI, Sponsor, and Principal Investigator(s). The procedure of treatment of such publication shall be determined by the publications committee. For purposes of publications pursuant to this Section, the results of the Study and other information gained in the course of this Agreement shall not be considered Sponsor’s Confidential Information.
Publication; Publicity. The provisions of Article 6 of the Research Agreement shall apply to the rights and obligations of the parties regarding publication and publicity during the term of this Agreement.
Publication; Publicity. Work Product may not be published or referred to, in whole or in part, by you without the prior express written consent of Sage. You shall not use the name, logo, trade name, service mark, or trademark, or any simulation, abbreviation, or adaptation of same, or the name of Sage or its subsidiaries for publicity, promotion, or similar uses without Sxxx’s prior written consent.
